A large clinical trial suggests that a daily multivitamin may influence the pace at which the body ages. Researchers led by Mass General Brigham report that older adults who took a daily multivitamin ...
Initial treatments are underway in randomized study of Acorn’s personalized autologous injectable for improving facial ...
The median fraction of the gland reaching ablative temperatures on intra-procedural MRI thermometry was 78% (IQR 71-85), with 68% of cases comprising whole gland ablation and 32% sub-total ablation: ...
Low dose alnodesertib plus gemcitabine met the primary endpoint of progression-free survival (PFS) versus gemcitabine alone ...
A phase 2 study of response-guided neoadjuvant sacituzumab govitecan and pembrolizumab (SG/P) in patients with early-stage triple-negative breast cancer: Results from the NeoSTAR trial. This is an ...
Preclinical studies in animals have already shown that GLP-1 drugs can reduce reward-seeking behavior. Early clinical work in humans has begun to hint at similar effects. A randomized trial of ...
Morning Overview on MSN
Study: Daily multivitamin may slow some biological aging markers
A daily multivitamin taken over two years slowed the pace of certain molecular aging markers in older adults, according to a ...
The COSMOS trial found that a daily multivitamin delayed biological aging by 2.7 to 5.1 months, and that this effect was more apparent in older adults who are already experiencing accelerated aging.
Controlled study designed to confirm previous compelling efficacy with preliminary data expected by the end of 2026 Pelareorep-based treatment regimen recently granted Fast Track Designation in 2L ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results